Prevalence of fAmilial hypobetalipopRoTeinemIa in psychiaTrIc pOpulatioN (PARTITION)
Familial Hypobetalipoproteinemia

About this trial
This is an interventional other trial for Familial Hypobetalipoproteinemia focused on measuring Psychiatry, hypobetalipoproteinemia, LDL-Cholesterol
Eligibility Criteria
Inclusion Criteria:
All patients hospitalized in one of the full-time adult psychiatric departments of Nantes University Hospital may be included, without maximum age limit.
Minors and patients under guardianship and tutorship may be included, taking into account the study population and the low risks and constraints of the study
Exclusion Criteria:
- minors under 15 years
- pregnant or nursing woman;
- simultaneous participation in another interventional research on a drug;
- not mastering the reading and writing of the French language well enough
Sites / Locations
- Nantes University Hospital Nantes
Arms of the Study
Arm 1
Experimental
Psychiatric population
At inclusion: Patients will have A Lipid Panel Test, other biological analyzes and a clinical assessment. In case of a low LDL-C level (≤ 0, 50 g/L), genetic analyzes will be performed to screen for genetic forms of hypobetalipoproteinemia (HBL). At 2- 4 weeks: for patients with HBL (LDL-C ≤ 0,50 g/L with no secondary cause of LDL-C reduction), another Lipid Panel Test will be performed to confirm the maintenance of the low LDL-C level. At 6 months : Patients with a HBL will perform a full biological examination, and the LDL-C levels and genetic analyzes will be confirmed. A dietary survey will be performed, together with a psychiatric assessment. The same numbers of matched controls will performed a quick telephone interview to collect the psychiatric characteristics.